An interventional study of MUAC Program and Standard Program in Malnutrition, sponsored by Epicentre. Completed at 1 site in Niger. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2021-02-10.
Sponsored by Epicentre · Not applicable, Interventional, and Treatment
The aim of this study is to provide comprehensive documentation of the relevant results and operational implications of this new model using Mid-Upper Arm Circumference (MUAC) as the single anthropometric criterion for admission, monitoring and exit of non- complicated in Niger.
This is a first operational experiment using Mid-Upper Arm Circumference (MUAC) as the single anthropometric criterion for the admission, monitoring and exit of the management of uncomplicated SAM (Severe Acute Malnutrition) in Niger, specific data as well as data from routine program will be collected to allow comprehensive documentation of all relevant results and operational implications of this new model. The experiment based on the use of the single anthropometric threshold for admission of a Mid-Upper Arm Circumference (MUAC)\<120 mm, which includes both children currently classified as having SAM (currently with PB \<115 mm) and acute malnutrition moderate (MAM, currently with a Mid-Upper Arm Circumference (MUAC)\<125 mm), as well as a follow-up of children with a Mid-Upper Arm Circumference (MUAC)≥ 120 mm, will identify how children respond to treatment and benefit of the spectrum of acute malnutrition.
Exclusion Criteria:
At the CRENAS, MUAC as unique anthropometric criteria for admission, monitoring, and care for the SAM output will be used. The criteria for admission include: * MUAC \<120 mm * Bilateral edema of grade + or ++ The criteria for release of care include: * MUAC ≥ 125 mm at 2 consecutive visits * Minimum stay 3 weeks in the program * Absence of acute medical complications * Absence of edema
Other: MUAC Program
Regular screenings in the communities on children between 6 and 59 months of age. Children with MUAC\<125 mm will be referred to Nutrition Centers for admission. The criteria for admission include: * MUAC\<115 mm and/or * Z score \<-3 and /or * Bilateral edema of grade + or ++ The criteria for release of care include: * MUAC ≥ 125 mm at 2 consecutive visits * Minimum stay 3 weeks in the program * Absence of acute medical complications * Absence of edema
Other: Standard Program
All children admitted to the PB program will receive standard care according to the national Protocol and that of MSF, including preventive and therapeutic care at admission as well as hospital care in case of clinical complications. There will be no change in the Protocol for the hospital care to the CRENI (Center of Intensive Nutritional Rehabilitation). RUTF (Ready-to-Use therapeutic food) will be distributed on a weekly basis according to the dosage of RUTF in the national protocol.
All children admitted to the standard program will receive standard care according to national and MSF protocols, including preventive and therapeutic care on admission as well as hospital care in case of clinical complications. RUTF will be distributed on a weekly basis according to the dosage of RUTF in the national protocol.
Nutritional recovery
Compare the average daily weight gain and the duration of the nutritional treatment per group compare the results of the PB programme, including the overall risk of recovery, transfer, of abandonment, of death, of PB and weight gain and the length of stay by age (6-23 months, compared to 24-59 months), compared the results of the program standard;
Time frame: 18 months
Readmission risks
Assessment of the risk of readmission 3 months after discharged of the child will be evaluated at 3 months (+/- one week) after discharged of the child
Time frame: 3 months
Deaths
Compare the death rate between the two groups
Time frame: 18 months
Documentation of the results
Document coverage of the nutrition program before and after the implementation of the
Time frame: 18 months
This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Epicentre